Sponsorship verdict
Sponsorship possible
One solid signal, not two. Worth applying, and worth asking about sponsorship early.
-
✓
Employer is on a government sponsor recordThe US Department of Labor certified 3 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest May 2026) — the step every H-1B hire needs first.
-
?
The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
-
?
No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area.
-
✓
Confirmed live todayWhen a source last listed this job as open.
Details and sources
- Employer is on a government sponsor record
- The US Department of Labor certified 3 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest May 2026) — the step every H-1B hire needs first. Source: LCA disclosure data (US Department of Labor (OFLC)).
- No salary bar for this route
- H-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence. It is not legal advice and never a guarantee: the employer and the immigration authority decide. Sign in to factor in where you can already work.
About the role
Ocular Therapeutix, Inc. (NASDAQ:OCUL) is a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye using its proprietary bioresorbable hydrogel-based formulation technology, ELUTYX™. Ocular Therapeutix has built a robust product pipeline of drug delivery solutions developed to reduce the complexity and burden of the current standard of care and position itself to become a leader in the ophthalmic space.
Outside of the ophthalmic realm and behind the doors of our headquarters in Bedford, MA, we strive to build a strong culture where employees can flourish and achieve their career goals. We encourage out of the box thinking, cross-functional collaboration, and creativity.
Position Summary:
As a Corporate Account Director, you'll play a pivotal role in ensuring seamless access and fostering growth for our company's products within designated corporate accounts. As an individual contributor at the director level, your primary focus will be developing and executing strategic account strategies while establishing and nurturing relationships with key stakeholders, including influential physicians and management at the C-suite level within the account's organization. You'll be instrumental in developing strategic approaches and leading the implementation of value-added solutions at the national and regional level implementing contracts that align with the company's growth initiatives while fostering strong, mutually beneficial partnerships.
Principal Duties and Responsibilities:
• Corporate Account Development: Identify new corporate accounts and develop comprehensive strategies tailored to individual strategic accounts, ensuring alignment with company objectives to achieve growth targets across DEXTENZA.
• Relationship Management: Proactively foster and maintain strong relationships with key stakeholders within the accounts, including C-level influencers, to understand their needs and address challenges and business opportunities both proactively and reactively.
• Value-Added Solutions: Identify and propose innovative solutions, negotiate contracts and services that enhance both patient and client outcomes. Be cognizant of overall impact of decisions working closely with commercial operations to ensure financial accountability (i.e. GTN, potential ASP impact)
• Sales Execution: Plan, coordinate, and execute activities within each strategic account to ensure contract initiatives are exercised. This includes implementing account strategies, leveraging available resources effectively, and partnering with sales and reimbursement in a compliant manner as needed.
• Collaboration and Coordination: Work closely with internal teams, including Sales, Marketing, and Market Access, to align strategies, address client needs, and ensure seamless coordination of internal and external resources needed for successful strategic account management. Create forums to ensure proactive communication across internal functions.
• Compensation: Compensation for this role is reflective of both the strategic and execution requirements and is a combination of MBO’s and overall account production
Qualifications:
• 8-10+ years of pharmaceutical, biotech, medical device, healthcare, market access, or strategic account management experience.
• Bachelor's degree required, preferably in Business, Healthcare Administration, Life Sciences, or a related field.
• Experience managing large corporate accounts, IDNs, GPOs, health systems, ASC networks, or physician organizations.
• Proven record of achieving sales, access, and revenue growth goals.
• Experience negotiating and implementing contracts and business agreements.
• Strong understanding of healthcare econom
Apply on company site ↗